- Home
- AHG vs ZYXI Comparison
AHG vs ZYXI Comparison
Compare AHG & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHG
- ZYXI
- Stock Information
- Founded
- AHG 2013
- ZYXI 1996
- Country
- AHG China
- ZYXI United States
- Employees
- AHG N/A
- ZYXI N/A
- Industry
- AHG Business Services
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AHG Consumer Discretionary
- ZYXI Health Care
- Exchange
- AHG Nasdaq
- ZYXI Nasdaq
- Market Cap
- AHG 765.9M
- ZYXI 72.3M
- IPO Year
- AHG N/A
- ZYXI N/A
- Fundamental
- Price
- AHG $1.18
- ZYXI $2.40
- Analyst Decision
- AHG
- ZYXI Buy
- Analyst Count
- AHG 0
- ZYXI 3
- Target Price
- AHG N/A
- ZYXI $6.00
- AVG Volume (30 Days)
- AHG 5.9K
- ZYXI 252.8K
- Earning Date
- AHG 07-15-2025
- ZYXI 07-24-2025
- Dividend Yield
- AHG N/A
- ZYXI N/A
- EPS Growth
- AHG N/A
- ZYXI N/A
- EPS
- AHG N/A
- ZYXI N/A
- Revenue
- AHG $8,454,946.00
- ZYXI $172,401,000.00
- Revenue This Year
- AHG N/A
- ZYXI N/A
- Revenue Next Year
- AHG N/A
- ZYXI $19.55
- P/E Ratio
- AHG N/A
- ZYXI N/A
- Revenue Growth
- AHG 281.19
- ZYXI N/A
- 52 Week Low
- AHG $0.74
- ZYXI $1.66
- 52 Week High
- AHG $2.35
- ZYXI $10.62
- Technical
- Relative Strength Index (RSI)
- AHG 43.34
- ZYXI 49.51
- Support Level
- AHG $1.29
- ZYXI $2.51
- Resistance Level
- AHG $1.30
- ZYXI $2.72
- Average True Range (ATR)
- AHG 0.08
- ZYXI 0.20
- MACD
- AHG -0.02
- ZYXI 0.02
- Stochastic Oscillator
- AHG 34.88
- ZYXI 48.78
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.